港股異動 | 譚仔國際(2217.HK)漲9% 月內累計漲約20%創3個月新高
格隆匯4月8日丨譚仔國際(2217.HK)大幅拉昇漲9%,月內累計漲幅近20%,報3.12港元創3個月新高價,總市值41.8億港元。公司旗下品牌“譚仔三哥米線”於日本的首間分店新宿中央通店於3月31日開業。格隆匯文章《譚仔國際(02217.HK):進擊的香港米線龍頭,與復甦中的全球餐飲市場》提到,日本是譚仔國際國際佈局的重要一步。日本已於3月22日全境解除防疫管制,消費正逐步復甦。券商預測2020~2025年日本消費者食品服務業總零售收入CAGR將維持在7%以上,譚仔國際在日本市場的增長預期將得到重估。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.